Statement of Scope
CONTROLLED SUBSTANCES BOARD
Relating to: | Scheduling thirty-eight (38) anabolic steroids |
1. Finding/nature of emergency:
N/A
2. Detailed description of the objective of the proposed rule:
The objective of the proposed rule is to schedule thirty-eight (38) anabolic steroids as a schedule III controlled substance under s. 961.11 (4), Stats. 3. Description of the existing policies relevant to the rule, new policies proposed to be included in the rule, and an analysis of policy alternatives:
On December 16, 2005, and July 30, 2012, the Department of Justice, Drug Enforcement Administration published its final rules in the Federal Register listing thirty-eight (38) anabolic steroids into schedule III of the federal Controlled Substances Act. The scheduling action were effective January 20, 2005, and August 29, 2012.
The Controlled Substances Board did not receive an objection to similarly treating thirty-eight (38) anabolic steroids as a Schedule III controlled substance under ch. 961, Stats within 30 days of the date of publication in the Federal Register of the final order designating thirty-eight (38) anabolic steroids as a controlled substance. Pursuant to s. 961.11 (4), Stats., the Controlled Substances Board took affirmative action to similarly treat thirty-eight (38) anabolic steroids under ch. 961, Stats. by repealing and recreating the following: 961.18 (7) ANABOLIC STEROIDS. Unless specifically excepted or listed in another schedule, any material, compound, mixture, or preparation containing any quantity of any of the following anabolic steroids, including any of their esters, ethers, isomers, esters or ethers of isomers, salts and salts of esters or ethers, isomers and esters or ethers of isomers that are theoretically possible within the specific chemical designation, except that such terms do not include an anabolic steroid that is expressly intended for administration through implants to cattle or other nonhuman species and that has been approved by the secretary of health and human services for such administration; and if any person prescribes, dispenses, or distributes such steroid for human use, the person shall be considered to have prescribed, dispensed, or distributed an anabolic steroid within the meaning of this section:
(a) 3beta,17-dihydroxy-5alpha-androstane.
(ag) 3alpha,17beta-dihydroxy-5alpha-androstane.
(ar) 5alpha-androstan-3,17-dione.
(b) 1-androstenediol (3beta,17beta-dihydroxy-5alpha-androst-1-ene; 3alpha,17beta-dihydroxy-5alpha-androst-1-ene).
(bg) 4-androstenediol.
(br) 5-androstenediol.
(c) 1-androstenedione.
(cg) 4-androstenedione.
(cr) 5-androstenedione.
(d) 13beta-ethyl-17beta-hydroxygon-4-en-3-one.
(dg) Bolasterone.
(dr) Boldenone.
(e) Boldione.
(eg) Calusterone.
(er) 4-chlorotestosterone, which is also called clostebol.
(f) Dehydrochloromethyltestosterone.
(fg) Delta1-dihydrotestosterone.
(fr) Desoxymethyltestosterone.
(g) 4-dihydrotestosterone, which is also called stanolone.
(gg) Drostanolone.
(gr) Ethylestrenol.
(h) Fluoxymesterone.
(hg) Formebulone, which is also called fromebolone.
(hr) Furazabol.
(i) 4-hydroxytestosterone.
(ig) 4-hydroxy-19-nortestosterone.
(ir) Mestanolone.
(j) Mesterolone.
(jg) Methandienone, which is also called methandrostenolone.
(jr) Methandriol.
